This APP aimed at health professionals provides diagnostic algorithms for neuromuscular diseases created by the Study Group Neuromuscular Disease.

The objective is twofold: on one hand help diagnose these diseases and the second is to increase the interest of all neurologists in these diseases, sometimes considered by many to be difficult to diagnose.

Application developed by the Study Group Neuromuscular Disease of the Spanish Society of Neurology (SEN), in collaboration with Genzyme, a Sanofi Company